Cart
sales@molnova.com
ISRIB
CAS No. 548470-11-7
ISRIB( —— )
Catalog No. M14973 CAS No. 548470-11-7
ISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 83 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 74 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 246 | In Stock |
|
| 100MG | 362 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameISRIB
-
NoteResearch use only, not for human use.
-
Brief DescriptionISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM.
-
DescriptionISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorPERK
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number548470-11-7
-
Formula Weight451.34
-
Molecular FormulaC22H24Cl2N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESClC1=CC=C(OCC(=O)NC2CCC(CC2)NC(=O)COC2=CC=C(Cl)C=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sidrauski C, et al. Elife. 2013, 2, e00498.
molnova catalog
related products
-
GSK2656157
GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay.
-
DB07268
DB07268 is a potent and selective JNK1 inhibitor.
-
Patritumab
Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
